1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Durata Therapeutics

Anonymous board for Durata Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    8
    Views:
    4,270
  2. Anonymous
    Replies:
    26
    Views:
    8,400
  3. Anonymous
    Replies:
    3
    Views:
    2,888
  4. Anonymous
    Replies:
    21
    Views:
    6,361
  5. Anonymous
    Replies:
    29
    Views:
    7,539
  6. Anonymous
    Replies:
    9
    Views:
    2,821
  7. Anonymous
    Replies:
    33
    Views:
    12,577
  8. Anonymous
    Replies:
    10
    Views:
    3,519
  9. Anonymous
    Replies:
    4
    Views:
    3,904
  10. Anonymous
    Replies:
    12
    Views:
    4,650
  11. Anonymous
    Replies:
    11
    Views:
    4,631
  12. Anonymous
    Replies:
    55
    Views:
    15,750
  13. Anonymous
    Replies:
    0
    Views:
    2,380
  14. Anonymous
    Replies:
    3
    Views:
    2,845
  15. Anonymous
    Replies:
    17
    Views:
    6,408
  16. Anonymous
    Replies:
    63
    Views:
    15,335
  17. Anonymous
    Replies:
    17
    Views:
    7,066
  18. Anonymous
    Replies:
    4
    Views:
    3,039
  19. Anonymous
    Replies:
    4
    Views:
    2,713
  20. Anonymous
    Replies:
    3
    Views:
    2,945

Thread Display Options

Loading...